Copper histidinate is expected to improve neurodevelopmental outcomes and survival in patients with Menkes disease, an X-linked recessive disease caused by mutations of the ATP7A copper ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback